HomeAMRX • NASDAQ
add
Amneal Pharmaceuticals Inc
Previous close
$11.35
Day range
$11.14 - $11.74
Year range
$6.69 - $11.74
Market cap
3.68B USD
Avg Volume
1.61M
P/E ratio
710.05
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 784.51M | 11.68% |
Operating expense | 198.85M | 10.60% |
Net income | 2.37M | 1,618.59% |
Net profit margin | 0.30 | 1,600.00% |
Earnings per share | 0.17 | 6.25% |
EBITDA | 149.46M | 1.84% |
Effective tax rate | 447.16% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 201.25M | 160.49% |
Total assets | 3.60B | 4.01% |
Total liabilities | 3.64B | 4.22% |
Total equity | -42.18M | — |
Shares outstanding | 314.17M | — |
Price to book | -32.43 | — |
Return on assets | 6.79% | — |
Return on capital | 9.21% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 2.37M | 1,618.59% |
Cash from operations | 118.45M | -16.45% |
Cash from investing | -22.46M | -8.46% |
Cash from financing | 59.44M | 164.37% |
Net change in cash | 154.74M | 438.71% |
Free cash flow | 6.30M | -94.13% |
About
Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States. Wikipedia
Founded
2002
Headquarters
Website
Employees
8,300
